Ipamorelin
Selective growth hormone secretagogue studied for its clean, targeted GH-releasing profile without significant impact on cortisol or prolactin.
Research Areas
Scientific Background
Ipamorelin is a pentapeptide and one of the most selective growth hormone secretagogues identified in research. It mimics ghrelin by binding the GHS-R1a receptor, stimulating GH release from the pituitary while minimally affecting cortisol, prolactin, or ACTH — a profile that distinguishes it from earlier secretagogues like GHRP-6.
Purity & Provenance
Why quality matters for research validity
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2). Research-grade material requires HPLC ≥98% purity with mass spec sequence confirmation.
Areas of Investigation
Laboratory Information
Technical specifications for research settings
This compound is intended for qualified scientific research only. Not for human or veterinary use. Not for diagnostic or therapeutic applications. Researchers must comply with all applicable regulations in their jurisdiction.
Store lyophilized at -20°C. Protect from light.
Lyophilized powder
>98% by HPLC
Soluble in bacteriostatic water and saline
For in vitro endocrine research applications.
Deepen Your Research
Published literature and clinical trial registries
Published Literature
Raun et al. (1998, European Journal of Endocrinology) characterized Ipamorelin as a highly selective GH secretagogue in preclinical models, demonstrating GH release comparable to GHRP-6 but without the cortisol and prolactin elevation.
Regulatory Classification
Ipamorelin is a research compound not approved by the FDA. Available for qualified research purposes only.
Important Research Notice
This information is compiled from scientific literature for educational purposes only. This website does not sell, distribute, or recommend any compounds for human use. All compounds discussed are for qualified research purposes only.